Exactech Company Profile (NASDAQ:EXAC)

About Exactech

Exactech logoExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee implants, hip implants, biologics and spine, extremity implants and other products. Its other products segment includes surgical instruments, bone cement and other implant product lines. The Company offers knee implant systems, including Exactech Knee System and Optetrak Logic. It offers various products and services for the healing and regeneration of bone and soft tissue. Its hip solutions address the continuum of hip arthroplasty. It offers solutions for shoulders with traumatic injuries. Its joint replacement products are used to repair or replace joints that have deteriorated as a result of injury or disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: EXAC
  • CUSIP: 30064E10
Key Metrics:
  • Previous Close: $25.15
  • 50 Day Moving Average: $26.10
  • 200 Day Moving Average: $26.73
  • 52-Week Range: $17.92 - $29.00
  • Trailing P/E Ratio: 22.26
  • Foreward P/E Ratio: 19.05
  • P/E Growth: 2.11
  • Market Cap: $356.73M
  • Outstanding Shares: 14,184,000
  • Beta: 0.84
Profitability:
  • Net Margins: 6.34%
  • Return on Equity: 6.81%
  • Return on Assets: 5.53%
Debt:
  • Debt-to-Equity Ratio: 0.08%
  • Current Ratio: 4.75%
  • Quick Ratio: 2.21%
Additional Links:
Companies Related to Exactech:

Analyst Ratings

Consensus Ratings for Exactech (NASDAQ:EXAC) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.00 (3.38% upside)

Analysts' Ratings History for Exactech (NASDAQ:EXAC)
Show:
DateFirmActionRatingPrice TargetDetails
4/13/2016Robert W. BairdUpgradeNeutral -> Outperform$21.00 -> $26.00View Rating Details
10/28/2015Northland SecuritiesLower Price TargetMarket Perform$22.00 -> $20.00View Rating Details
7/29/2015Canaccord GenuityReiterated RatingHold$22.00View Rating Details
3/19/2015GabelliInitiated CoverageBuy$37.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Exactech (NASDAQ:EXAC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2017Q416$0.32$66.00 millionN/AView Earnings Details
10/31/2016Q316$0.22$0.22$58.69 million$59.90 millionViewN/AView Earnings Details
8/1/2016Q216$0.30$0.31$64.18 million$66.10 millionViewN/AView Earnings Details
4/26/2016Q116$0.29$0.31$63.63 million$65.30 millionViewN/AView Earnings Details
2/16/2016Q415$0.28$0.29$61.29 million$62.70 millionViewListenView Earnings Details
10/27/2015Q315$0.23$0.20$58.46 million$56.20 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.26$62.13 million$61.50 millionViewListenView Earnings Details
4/28/2015Q115$0.30$0.29$63.71 million$61.40 millionViewN/AView Earnings Details
2/17/2015Q414$0.33$0.36$63.30 million$63.30 millionViewN/AView Earnings Details
10/21/2014Q314$0.25$0.21$58.60 million$57.90 millionViewN/AView Earnings Details
7/28/2014Q214$0.30$0.30$63.80 million$63.92 millionViewN/AView Earnings Details
4/21/2014Q114$0.29$0.30$63.05 million$63.30 millionViewN/AView Earnings Details
2/19/2014Q413$0.31$0.33$63.20 million$61.60 millionViewN/AView Earnings Details
10/22/2013Q313$0.21$0.23$55.36 million$55.70 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.25$0.27$58.42 million$60.60 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.28$0.29$58.20 million$59.30 millionViewN/AView Earnings Details
10/30/2012Q312$0.17$0.19$50.20 million$51.30 millionViewN/AView Earnings Details
7/31/2012$0.23$0.23ViewN/AView Earnings Details
5/1/2012$0.23$0.25ViewN/AView Earnings Details
2/28/2012$0.25$0.18ViewN/AView Earnings Details
11/1/2011$0.20$0.15ViewN/AView Earnings Details
8/2/2011$0.26$0.28ViewN/AView Earnings Details
5/3/2011$0.27$0.28ViewN/AView Earnings Details
2/28/2011$0.23$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Exactech (NASDAQ:EXAC)
Current Year EPS Consensus Estimate: $1.16 EPS
Next Year EPS Consensus Estimate: $1.32 EPS

Dividends

Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Exactech (NASDAQ:EXAC)
Insider Ownership Percentage: 29.80%
Institutional Ownership Percentage: 64.24%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/3/2016James G BinchDirectorSell600$22.61$13,566.00View SEC Filing  
8/25/2016Fern WattsDirectorSell1,100$27.68$30,448.00View SEC Filing  
8/22/2016Bruce E ThompsonSVPSell1,433$27.97$40,081.01View SEC Filing  
8/19/2016David W PettyCEOSell3,550$27.75$98,512.50View SEC Filing  
7/1/2016Joel C PhillipsCFOSell3,000$26.75$80,250.00View SEC Filing  
6/8/2016Gary J MillerEVPSell9,800$25.16$246,568.00View SEC Filing  
6/7/2016Bruce E ThompsonSVPSell2,000$25.07$50,140.00View SEC Filing  
6/3/2016James G BinchDirectorSell600$24.86$14,916.00View SEC Filing  
6/2/2016Gary J MillerEVPSell3,381$25.11$84,896.91View SEC Filing  
5/25/2016Gary J MillerEVPSell9,319$25.10$233,906.90View SEC Filing  
5/18/2016Gary J MillerEVPSell9,664$24.37$235,511.68View SEC Filing  
5/9/2016Joel C PhillipsCFOSell3,900$23.13$90,207.00View SEC Filing  
5/5/2016James G BinchDirectorSell1,870$23.00$43,010.00View SEC Filing  
5/3/2016Fern WattsDirectorSell2,000$22.76$45,520.00View SEC Filing  
4/29/2016Betty A PettyVPSell18,000$22.65$407,700.00View SEC Filing  
4/27/2016Gary J MillerEVPSell9,851$24.06$237,015.06View SEC Filing  
4/26/2016Gary J MillerEVPSell7,985$23.11$184,533.35View SEC Filing  
4/25/2016Gary J MillerEVPSell4,725$23.14$109,336.50View SEC Filing  
3/31/2016Gary J MillerEVPSell7,000$19.95$139,650.00View SEC Filing  
3/10/2016Joel C PhillipsCFOSell2,000$18.58$37,160.00View SEC Filing  
3/8/2016Betty A PettyVPSell15,964$19.06$304,273.84View SEC Filing  
3/7/2016Donna M EdwardsVPSell10,000$18.85$188,500.00View SEC Filing  
3/3/2016Gary J MillerEVPSell7,017$19.23$134,936.91View SEC Filing  
3/3/2016William B LocanderDirectorSell2,435$19.25$46,873.75View SEC Filing  
12/10/2015James G BinchDirectorSell1,500$17.03$25,545.00View SEC Filing  
12/9/2015Fern WattsDirectorSell1,200$17.32$20,784.00View SEC Filing  
12/1/2015Bruce E. ThompsonSVPSell21,904$17.57$384,853.28View SEC Filing  
11/24/2015Bruce E. ThompsonSVPSell900$17.75$15,975.00View SEC Filing  
9/1/2015Bruce E. ThompsonSVPSell2,107$19.45$40,981.15View SEC Filing  
5/28/2015Joel C PhillipsCFOSell5,000$21.76$108,800.00View SEC Filing  
5/20/2015William B LocanderDirectorSell3,350$21.50$72,025.00View SEC Filing  
5/18/2015Fern WattsDirectorSell2,200$21.21$46,662.00View SEC Filing  
5/4/2015Joel C PhillipsCFOSell2,700$21.67$58,509.00View SEC Filing  
3/20/2015Gary J MillerEVPSell32,800$24.95$818,360.00View SEC Filing  
2/24/2015R William PettyChairmanSell45,067$23.08$1,040,146.36View SEC Filing  
2/2/2015Betty A PettyVPSell7,500$20.74$155,550.00View SEC Filing  
1/8/2015Gary J MillerEVPSell4,145$23.17$96,039.65View SEC Filing  
12/3/2014Gary J MillerEVPSell5,000$21.83$109,150.00View SEC Filing  
11/25/2014Betty A PettyMajor ShareholderSell12,500$21.86$273,250.00View SEC Filing  
11/25/2014Bruce E ThompsonSVPSell6,500$22.05$143,325.00View SEC Filing  
10/31/2014Joel C PhillipsCFOSell5,000$21.44$107,200.00View SEC Filing  
9/5/2014R William PettyMajor ShareholderSell25,000$23.68$592,000.00View SEC Filing  
8/25/2014Albert H BursteinDirectorSell8,852$23.73$210,057.96View SEC Filing  
7/1/2014Gary J MillerEVPSell12,392$26.21$324,794.32View SEC Filing  
6/26/2014Gary J MillerEVPSell1,894$25.06$47,463.64View SEC Filing  
6/25/2014Gary J MillerEVPSell16,356$25.33$414,297.48View SEC Filing  
6/10/2014Joel C PhillipsCFOSell5,000$24.77$123,850.00View SEC Filing  
6/5/2014Bruce E ThompsonSVPSell1,667$23.50$39,174.50View SEC Filing  
6/5/2014Joel C PhillipsCFOSell5,000$23.21$116,050.00View SEC Filing  
5/29/2014Bruce E ThompsonSVPSell1,588$23.00$36,524.00View SEC Filing  
5/12/2014David PettyCEOSell10,287$20.99$215,924.13View SEC Filing  
5/8/2014David PettyCEOSell7,976$21.51$171,563.76View SEC Filing  
4/24/2014Bruce ThompsonSVPSell2,412$23.78$57,357.36View SEC Filing  
4/23/2014William LocanderDirectorSell4,500$23.18$104,310.00View SEC Filing  
2/28/2014William LocanderDirectorSell1,819$23.16$42,128.04View SEC Filing  
12/5/2013R William PettyCEOSell10,000$23.67$236,700.00View SEC Filing  
11/12/2013Bruce ThompsonSVPSell3,079$23.35$71,894.65View SEC Filing  
8/22/2013William LocanderDirectorSell1,521$19.05$28,975.05View SEC Filing  
7/15/2013Gary J MillerEVPSell10,250$20.07$205,717.50View SEC Filing  
7/8/2013Gary J MillerEVPSell1,000$20.00$20,000.00View SEC Filing  
6/17/2013Gary J MillerEVPSell8,125$18.98$154,212.50View SEC Filing  
6/5/2013R William PettyCEOSell3,885$18.00$69,930.00View SEC Filing  
6/4/2013R William PettyCEOSell14,257$18.01$256,768.57View SEC Filing  
5/28/2013R William PettyCEOSell20,000$18.21$364,200.00View SEC Filing  
5/22/2013R William PettyCEOSell11,493$18.13$208,368.09View SEC Filing  
5/17/2013R William PettyCEOSell17,472$18.05$315,369.60View SEC Filing  
5/16/2013R William PettyCEOSell22,893$18.22$417,110.46View SEC Filing  
5/9/2013R William PettyCEOSell10,000$18.25$182,500.00View SEC Filing  
5/8/2013David W PettyPresidentSell8,000$18.35$146,800.00View SEC Filing  
12/4/2012R William PettyCEOSell14,048$16.29$228,841.92View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Exactech (NASDAQ:EXAC)
DateHeadline
sbwire.com logoWorldwide Demineralized Allografts Market: Evolving Market Trends and Dynamics (NASDAQ:EXAC)
www.sbwire.com - February 15 at 4:10 AM
4-traders.com logoExactech : Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call (NASDAQ:EXAC)
www.4-traders.com - February 14 at 11:08 PM
bizjournals.com logoThese drug and medical device companies made the most payments to N.Y.C. hospitals (NASDAQ:EXAC)
www.bizjournals.com - February 14 at 3:54 AM
finance.yahoo.com logoExactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call (NASDAQ:EXAC)
finance.yahoo.com - February 13 at 5:53 PM
einnews.com logoBone Graft Substitutes Market Analysis and In-depth Research on Market Size, Trends, Growth Factors and Forecast 2027 (NASDAQ:EXAC)
www.einnews.com - February 9 at 5:42 PM
openpr.com logoTissue Transplantation Products and Services Market - Trends, Outlook, and Opportunity Analysis, 2016-2024 (NASDAQ:EXAC)
www.openpr.com - February 8 at 5:37 PM
biz.yahoo.com logoEXACTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:EXAC)
biz.yahoo.com - February 8 at 5:37 PM
News IconExactech sells off spine business and restructures (NASDAQ:EXAC)
orthostreams.com - February 3 at 10:31 PM
4-traders.com logoExactech : ChoiceSpine Acquires Exactech's Spine Assets (NASDAQ:EXAC)
www.4-traders.com - February 2 at 3:45 AM
finance.yahoo.com logoKnee Reconstruction Devices Market by Product Type, Partial, and Revision Implants, and Geography - Global Analysis and Forecast to 2020 (NASDAQ:EXAC)
finance.yahoo.com - February 1 at 5:41 PM
streetinsider.com logoExactech (EXAC) Sells Spine Assets, Announces Restructuring Charges (NASDAQ:EXAC)
www.streetinsider.com - January 31 at 5:48 PM
News IconGlobal Hip and Knee Reconstruction Devices Industry Trends & Forecasts to 2022 (NASDAQ:EXAC)
www.medgadget.com - January 31 at 5:48 PM
News IconPatient Satisfaction Reporting After Total Hip Arthroplasty: A Systematic Review (NASDAQ:EXAC)
www.healio.com - January 31 at 5:48 PM
finance.yahoo.com logoExactech Announces Divestiture of Spine Assets and Restructuring Charges (NASDAQ:EXAC)
finance.yahoo.com - January 31 at 5:48 PM
finance.yahoo.com logo4:04 pm Exactech divests its Spine & Biologics biz segment; guides FY17 EPS & rev in-line (NASDAQ:EXAC)
finance.yahoo.com - January 31 at 5:48 PM
feeds.reuters.com logoBRIEF-Exactech reports divestiture of spine assets and restructuring charges (NASDAQ:EXAC)
feeds.reuters.com - January 31 at 5:19 PM
News IconBone Grafts Market to Register a Strong Growth By 2021 – Persistence Market Research (NASDAQ:EXAC)
military-technologies.net - January 27 at 11:48 PM
sbwire.com logoGlobal Platelet Rich Plasma (PRP) Market Expanding at a CAGR of 12.50% from 2024 (NASDAQ:EXAC)
www.sbwire.com - January 25 at 6:27 PM
openpr.com logoPlatelet Rich Plasma (PRP) Market By Analysis of Major Industry Segments 2024 (NASDAQ:EXAC)
www.openpr.com - January 24 at 10:46 PM
News IconPlatelet Rich Plasma (PRP) Market Analysis by Segments, Size and Forecast 2016 - 2024 (NASDAQ:EXAC)
reports.pr-inside.com - January 24 at 10:46 PM
News IconHip Replacement Market is Expected to Expand US$ 9.1 Billion by 2024 End (NASDAQ:EXAC)
www.medgadget.com - January 24 at 10:46 PM
capitalcube.com logoETFs with exposure to Exactech, Inc. : January 20, 2017 (NASDAQ:EXAC)
www.capitalcube.com - January 20 at 6:22 PM
openpr.com logoOrthopedic Devices Market is Expected to Grow at a CAGR of 4.9% from 2013 to 2019 (NASDAQ:EXAC)
www.openpr.com - January 19 at 11:44 PM
capitalcube.com logoExactech, Inc. – Value Analysis (NASDAQ:EXAC) : January 19, 2017 (NASDAQ:EXAC)
www.capitalcube.com - January 19 at 6:44 PM
capitalcube.com logoExactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : January 18, 2017 (NASDAQ:EXAC)
www.capitalcube.com - January 18 at 5:29 PM
sbwire.com logoPlatelet Rich Plasma (PRP) Market to Expanding at a CAGR of 12.50% Between 2016 and 2024 (NASDAQ:EXAC)
www.sbwire.com - January 17 at 5:49 PM
News IconHip and Knee Orthopedic Surgical Implants Market by Region & Data Validation, Analysis and Forecast 2022 (NASDAQ:EXAC)
empowerednews.net - January 16 at 9:35 AM
News IconPlatelet Rich Plasma Market : Asia Pacific Industry Analysis, Size, Share, Growth, Trends and Forecast 2017-2023 (NASDAQ:EXAC)
www.medgadget.com - January 16 at 9:35 AM
News IconStricklin Gets To Work Meeting Gator Nation (NASDAQ:EXAC)
floridagators.com - January 12 at 3:42 AM
News IconOrthopedic Devices Market – Technology Trends and Future Advances in Orthopedic Devices 2019 (NASDAQ:EXAC)
www.medgadget.com - January 8 at 4:30 AM
News IconHip & Knee Reconstruction Devices Global Market Key Developments, Outlook, Analysis & Forecast to 2022 (NASDAQ:EXAC)
empowerednews.net - January 7 at 4:29 AM
prnewswire.com logoPlatelet Rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024 (NASDAQ:EXAC)
www.prnewswire.com - January 6 at 3:56 AM
openpr.com logoCompetitive Landscape for PRP Market Key Trends 2024 (NASDAQ:EXAC)
www.openpr.com - January 6 at 3:56 AM
sbwire.com logoPlatelet Rich Plasma Market by 2024: Asia Pacific to Outshine North America and Europe (NASDAQ:EXAC)
www.sbwire.com - January 6 at 3:56 AM
News IconExactech, Inc. EXAC Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:EXAC)
www.bioportfolio.com - January 6 at 3:56 AM
openpr.com logoDemineralized Allografts Market: End users are tertiary care hospitals, orthopedics hospitals, orthopedics OPD, and corporate hospitals (NASDAQ:EXAC)
www.openpr.com - January 2 at 5:21 PM
News IconGlobal Hydroxyapatite-coated Femoral Components Market Analysis, Share, Trends and Forecast by 2021- Market Research report 2016 (NASDAQ:EXAC)
www.medgadget.com - December 28 at 5:02 PM
sbwire.com logoBusiness Segments for Platelet-Rich Plasma Market in Worldwide by 2024 (NASDAQ:EXAC)
www.sbwire.com - December 23 at 10:22 PM
openpr.com logoStrategic Overview for Platelet-Rich Plasma Market Trends 2016 to 2024 (NASDAQ:EXAC)
www.openpr.com - December 23 at 3:21 AM
News IconGlobal Platelet-Rich Plasma (PRP) Market: Shifting Focus of Leading Players towards Emerging Economies to Influence Market’s Future, says TMR (NASDAQ:EXAC)
www.medgadget.com - December 17 at 3:42 AM
News IconEurope's hip prosthesis market growth for 2016 insights shared in detailed report (NASDAQ:EXAC)
www.whatech.com - December 16 at 5:38 PM
News IconGlobal Market Study on Hip Replacement: North America to Register a CAGR of 4.3% Between 2016 and 2024 (NASDAQ:EXAC)
www.kait8.com - December 14 at 4:07 PM
4-traders.com logoExactech : Assigned Patent (NASDAQ:EXAC)
www.4-traders.com - December 14 at 4:07 PM
News IconHip and Knee Orthopedic Surgical Implants Market 2015 Overview, Trends & Analysis, Forecasts 2022 (NASDAQ:EXAC)
emailwire.com - December 14 at 3:46 AM
News IconAlachua County region outpaces state in many areas (NASDAQ:EXAC)
www.gainesville.com - December 8 at 10:46 PM
newsmaker.com.au logoHip and Knee Orthopedic Surgical Implants Market Analysis, Size, Trends, Share, Report and Forecast to 2022 (NASDAQ:EXAC)
www.newsmaker.com.au - December 8 at 5:44 PM
News IconAnkle Replacement – Medical Devices Pipeline Assessment, 2016 (NASDAQ:EXAC)
pressreleaseping.com - December 6 at 10:25 PM
finance.yahoo.com logoKnee Implants Market Analysis By Procedure Type (Total, Partial, Revision Knee Replacement), By Component … (NASDAQ:EXAC)
finance.yahoo.com - December 6 at 11:11 AM
News IconUnited States, EU, Japan, China, India and Southeast Asia Hip Reconstruction Market Size, Status and Forecast 2021 (NASDAQ:EXAC)
www.rnrmarketresearch.com - December 3 at 9:16 AM
streetinsider.com logoForm 4 EXACTECH INC For: Nov 30 Filed by: Smith Richard Craig (NASDAQ:EXAC)
www.streetinsider.com - December 3 at 9:16 AM

Social

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

Where is Exactech's stock going? Where will Exactech's stock price be in 2017?

1 equities research analysts have issued twelve-month target prices for Exactech's stock. Their predictions range from $26.00 to $26.00. On average, they expect Exactech's share price to reach $26.00 in the next twelve months.

When will Exactech announce their earnings?

Exactech is scheduled to release their next quarterly earnings announcement on Tuesday, February, 21st 2017.

Who owns Exactech stock?

Exactech's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.30%), Gamco Investors INC. ET AL (4.62%), Gabelli Funds LLC (2.09%), State Street Corp (1.73%), Royce & Associates LP (1.69%) and Teton Advisors Inc. (1.64%). Company insiders that own Exactech stock include Betty A Petty, Bruce E Thompson, David W Petty, Donna M Edwards, Fern Watts, Gary J Miller, James G Binch, Joel C Phillips, R William Petty and William B Locander.

Who sold Exactech stock? Who is selling Exactech stock?

Exactech's stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, AQR Capital Management LLC, Oxford Asset Management, Gamco Investors INC. ET AL, GSA Capital Partners LLP, Martingale Asset Management L P and O Shaughnessy Asset Management LLC. Company insiders that have sold Exactech stock in the last year include Betty A Petty, Bruce E Thompson, David W Petty, Donna M Edwards, Fern Watts, Gary J Miller, James G Binch, Joel C Phillips and William B Locander.

Who bought Exactech stock? Who is buying Exactech stock?

Exactech's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Allianz Asset Management AG, Dimensional Fund Advisors LP, State Street Corp, Bowling Portfolio Management LLC, Royce & Associates LP, Renaissance Technologies LLC and Bessemer Group Inc..

How do I buy Exactech stock?

Shares of Exactech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Exactech stock cost?

One share of Exactech stock can currently be purchased for approximately $25.15.

Exactech (NASDAQ:EXAC) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Earnings History Chart

Earnings by Quarter for Exactech (NASDAQ:EXAC)

Dividend History Chart

Dividend Payments by Quarter for Exactech (NASDAQ:EXAC)

Last Updated on 2/20/2017 by MarketBeat.com Staff